Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection-Reference-Cited by-同舟云学术

Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection

Published:2019-07 Issue:3 Volume:102 Page:352-353
ISSN:0195-6701
Container-title:Journal of Hospital Infection
language:en
Short-container-title:Journal of Hospital Infection

Author:

Goldenberg S.D.,Wigglesworth N.,Wade P.,Price N.M.

Funder

Astellas

MSD

Pfizer

Shionogi

Cardiome

Gilead

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. The effect of using fidaxomicin on recurrent Clostridium difficile infection?;Biggs;J Hosp Infect,2019

2. The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations;Goldenberg;Eur J Clin Microbiol Infect Dis,2016

3. Fecal Microbiota Transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection;Loberg Hvas;Gastroenterology,2019

4. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial;Guery;Lancet Infect Dis,2018

5. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin;Biswas;J Hosp Infect,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States;Infectious Diseases and Therapy;2024-02

2. Risk Factors for Recurrence of Clostridioides difficile in Hospitalized Patients;Journal of Infection and Public Health;2021-11